Cargando…
Primary hepatic Epstein–Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report
BACKGROUND: Hepatic masses are relatively common findings, and the diagnostic approach often begins by identifying patient and mass characteristics that are risk factors for malignancy. Chronic immunosuppression is a known risk factor for various malignancies, and azathioprine in particular has been...
Autores principales: | Marell, Paulina S., Shi, Min, Wingo, Majken T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152705/ https://www.ncbi.nlm.nih.gov/pubmed/37127672 http://dx.doi.org/10.1186/s13256-023-03907-z |
Ejemplares similares
-
Epstein-Barr Virus-Negative Diffuse Large B-Cell Post-transplant Lymphoma in an Epstein-Barr Virus-Positive Recipient
por: Lee, Charlotte, et al.
Publicado: (2021) -
Epstein-Barr Virus-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma in an Immunocompetent Patient
por: Park, Ji-Hye, et al.
Publicado: (2014) -
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression
por: Tracy, Sean I., et al.
Publicado: (2018) -
Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023) -
Spontaneous Remission of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly
por: Mizuno, T., et al.
Publicado: (2013)